Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake
Date Insider Transaction Shares Price Value Owned after
2026-05-21 Su Zhen Director Grant or award +15,508 15,508
2025-05-28 Su Zhen Director Grant or award · Nonstatutory Stock Option (right to buy) +4,600 4,600
2024-05-29 Su Zhen Director Grant or award · Nonstatutory Stock Option (right to buy) +50,587 50,587
2023-08-31 Su Zhen Director Grant or award · Nonstatutory Stock Option (right to buy) +68,000 68,000

Page 1 of 1 · 4 trades